Sub-study of GSK Protocol TB-018: Collection and storage of biological samples for evaluation of correlates of tuberculosis
Phase of Trial: Phase IV
Latest Information Update: 06 Feb 2017
At a glance
- Drugs GSK 692342 (Primary)
- Indications Tuberculosis
- Focus Biomarker; Therapeutic Use
- Sponsors Aeras
- 31 Jan 2017 Status changed from active, no longer recruiting to completed.
- 03 Feb 2016 Planned End Date changed from 1 Aug 2017 to 1 Nov 2016, according to ClinicalTrials.gov record.
- 03 Feb 2016 Planned primary completion date changed from 1 Aug 2017 to 1 Nov 2016, according to ClinicalTrials.gov record.